Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Top three strategies for quitting smoking: e-cigarettes, varenicline, and cytisine. New review summarises data from fourteen Cochrane Tobacco Addiction Reviews of over 150,000 participants, providing evidence-based guidance for smokers seeking to quit.

A broken cigarette lies next to scattered tobacco, spelling out the word 'STOP' on a light blue background. The image symbolises the act of quitting smoking.

A new review led by researchers from the Nuffield Department of Primary Care Health Sciences at the University of Oxford highlights three top strategies for quitting smoking.

The review, published in the journal Addiction, summarised findings from fourteen Cochrane Tobacco Addiction Reviews of 157,179 participants across 319 studies. Dr Jonathan Livingstone-Banks, lead author of the review, and his colleagues identified three top strategies for quitting smoking:

  1. Nicotine e-cigarettes
  2. Varenicline (a prescription medication sold under brand names like Chantix and Champix)
  3. Cytisine (a plant-based compound available by prescription in the UK and over-the-counter in some countries).

These methods are most effective when combined with behavioural support, such as counselling.

Dr Livingstone-Banks, lead author of the review, said,

 

"Quitting smoking is challenging, but tobacco is uniquely deadly among legal consumer products. It's crucial to seek help when trying to quit. There's a range of effective support available, and our research shows that cytisine, varenicline and e-cigarettes are all evidence-based ways to significantly increase people's chances of successfully quitting smoking."

The review also highlighted strong evidence for the effectiveness of nicotine replacement therapy (NRT), especially when patches are combined with fast-acting forms like gum or lozenges. Bupropion, another prescription medication, was also found to be effective.

Key findings from the study include:

  • High-certainty evidence that e-cigarettes with nicotine increase quit rates compared to NRT and non-nicotine e-cigarettes
  • Combination NRT (using patches with gum or lozenges) is more effective than single-form NRT
  • Behavioural counselling and financial incentives can be effective even without additional medication.

This review summarises the latest work by the Cochrane Tobacco Addiction Group, building on almost 30 years of systematic reviews providing high-quality evidence to inform smoking cessation strategies.

The research team emphasises that while these methods are effective, quitting smoking remains difficult for many people. They encourage smokers to seek support and try different methods if needed, as what works best can vary from person to person.

For support with stopping smoking visit: www.nhs.uk/better-health/quit-smoking

 

Contact our communications team

Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.